Sonnet Biotherapeutics Holdings Inc. Stock
Currently there is a rather positive sentiment for Sonnet Biotherapeutics Holdings Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 10 € there is potential for a 5334.78% increase which would mean more than doubling the current price of 0.18 € for Sonnet Biotherapeutics Holdings Inc..
Our community identified positive and negative aspects for Sonnet Biotherapeutics Holdings Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Sonnet Biotherapeutics Holdings Inc. stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of Sonnet Biotherapeutics Holdings Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sonnet Biotherapeutics Holdings Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Sonnet Biotherapeutics Holdings Inc. | - | - | - | - | - | - | - |
SSP Group plc | -1.770% | 0.909% | -8.264% | -20.144% | -12.598% | -37.989% | -70.010% |
Skylark Co Ltd | 0.760% | 3.125% | -7.692% | 10.000% | 2.326% | 9.091% | -8.966% |
J D Wetherspoon plc | 1.200% | -3.977% | -0.880% | 7.098% | -9.237% | -45.589% | - |
Comments
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $75.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SONN provided by MarketBeat
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $7.00 price target on the stock.
Show more
Ratings data for SONN provided by MarketBeat
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SONN provided by MarketBeat